A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.12486 ↗At a glance
Journal article in Journal of Extracellular Vesicles, 2024. Written by Shizhen Shen and 12 co-authors. Institution: Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School …. Major MEDLINE topics: Extracellular Vesicles, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms. Cited 3 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Topics: Onkologische Pflege
Abstract (original language)
Epithelial ovarian cancer (EOC) is an often‐fatal malignancy marked by the development of resistance to platinum‐based chemotherapy. Thus, accurate prediction of platinum drug efficacy is crucial for strategically selecting postoperative interventions to mitigate the risks associated with suboptimal therapeutic outcomes and adverse effects. Tissue‐derived extracellular vesicles (tsEVs), in contrast to their plasma counterparts, have emerged as a powerful tool for examining distinctive attributes of EOC tissues. In this study, 4D data‐independent acquisition (DIA) proteomic sequencing was performed on tsEVs obtained from 58 platinum‐sensitive and 30 platinum‐resistant patients with EOC. The analysis revealed a notable enrichment of differentially expressed proteins that were predominantly associated with immune‐related pathways. Moreover, pivotal immune‐related proteins (IRPs) were identified by LASSO regression. These factors, combined with clinical parameters selected through univariate logistic regression, were used for the construction of a model employing multivariate logistic regression. This model integrated three tsEV IRPs, CCR1, IGHV_35 and CD72, with one clinical parameter, the presence of postoperative residual lesions. Thus, this model could predict the efficacy of initial platinum‐based chemotherapy in patients with EOC post‐surgery, providing prognostic insights even before the initiation of chemotherapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Gynecologic Oncology, School of Medicine, Women's Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
ORCID profiles: Xiaodong Cheng
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Cite
APA
Shen, S., Wang, C., Gu, J., Song, F., Wu, X., Qian, F., Chen, X., Wang, L., Peng, Q., Xing, Z., Gu, L., Wang, F., & Cheng, X. (2024). A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12486
Vancouver
Shen S, Wang C, Gu J, Song F, Wu X, Qian F, et al. A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12486
BibTeX
@article{Shen2024,
author = {Shen, Shizhen and Wang, Conghui and Gu, Jiaxin and Song, Feifei and Wu, Xiaodong and Qian, Fangfang and Chen, Xiaojing and Wang, Lingfang and Peng, Qiaohua and Xing, Ziyu and Gu, Lingkai and Wang, Fenfen and Cheng, Xiaodong},
title = {A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.12486}
}
EUVIMED